Table 3.
Participant demographic and clinical characteristics.
| Mean age (years, standard deviation) | 62.8 (17.83) | |
|---|---|---|
| Sex | Female | 4 (67%) |
| Male | 2 (33%) | |
| Aetiology | ||
| Brain tumour (n = 3), location | Anaplastic astrocytoma, right temporal lobe | 1 (17%) |
| Meningioma, sella/suprasellar/cavernous sinus | 1 (17%) | |
| Glioblastoma, left occipito-temporal lobe | 1 (17%) | |
| Stroke (n = 3), location | Temporal lobe | 1 (17%) |
| Parietal lobe | 1 (17%) | |
| Occipital lobe | 1 (17%) | |
| Visual acuity (median, range) | Better eye Snellen BCVA | 20/30 (HM to 20/20) |
| Worse eye Snellen BCVA | 20/45 (NLP to 20/20) | |
| Low vision impact | BCVA <20/400 | 1 (17%) |
| Homonymous hemianopia | 5 (83%) | |
| Survival throughout the study | Alive | 5 (83%) |
| Deceased | 1 (17%) |
BCVA = best corrected visual acuity; HM = hand motion; NLP = no light perception.